1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > Asian Internal Neurostimulaiton/Neuromodulation Market, by Modality -Forecast to 2019

The Asia-Pacific internal neurostimulation/neuromodulation market is estimated to register a CAGR of 13.8% between 2014 and 2019. Although the mature market of Japan holds the largest share in the internal neurostimulation/neuromodulation market, India is estimated to register the highest CAGR of 15.3% during the forecast period. The growth of the internal neurostimulation/neuromodulation market in Asia-Pacific is driven by public initiatives to increase awareness, technological developments, growing demand for the use of advanced technologies, and increasingly aging population. However, factors including lack of skilled professional and unfavorable reimbursement scenario are restraining the growth of this market.

In this report, the Asia-Pacific internal neurostimulation/neuromodulation market has been broadly classified into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and gastric neurostimulator. The Spinal Cord Stimulator segment is further categorized by application into Chronic Pain, Failed Back Surgery Syndrome, Ischemic Pain and others. Likewise, Deep Brain Stimulation market has its application in Parkinson's Disease, Tremor, Depression, and others including Chronic Pain, Dystonia, Tourette's Syndrome, and Alzheimer's disease. Sacral Nerve Stimulation market has applications in Urinary Incontinence and Fecal Incontinence, while Vagus Nerve Stimulator comprises Epilepsy and other applications. Gastric Stimulation includes gastroparesis and others. The gastric neurostimulator market segment is estimated to register the highest CAGR between 2014 and 2019. The driver for this market is the increasing number of people suffering from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which offers a significant growth opportunity for players in this segment.

In terms of countries, Japan is estimated to command the largest share of 53.0% of the Asia-Pacific internal neurostimulation/neuromodulation market in 2014, followed by China. The internal neurostimulation/neuromodulation market in the Japan is primarily driven by factors including aging population, technological advancements, and rising government initiatives.

The Asia-Pacific Internal neurostimulation/neuromodulation market is a competitive market with a number of market players with niche technologies. As of 2014, this market was dominated by Medtronic Inc. (U.S.), St. Jude Medical Inc. (U.S.), Boston Scientific Inc. (U.S.) Depuy Synthes, Inc. (U.S.), Cyberonics Inc. (U.S.), Enteromedics Inc. (U.S.), and Uroplasty, Inc. (U.S.) New product launches and partnerships, agreements, collaborations, and joint ventures are the main strategies adopted by most market players to achieve growth.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the Asia-Pacific internal neurostimulation/neuromodulation market, regulatory policies of different countries, government initiatives, drivers, restraints, and upcoming opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on internal neuromodulation

Table Of Contents

Asian Internal Neurostimulaiton/Neuromodulation Market, by Modality -Forecast to 2019
TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET SEGMENTATION and COVERAGE 14
1.3 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 INTEGRATED ECOSYSTEM OF THE INTERNAL NEUROSTIMULATION / NEUROMODULATION MARKET 16
2.2 ARRIVING AT THE NEUROMOSTIMULATION/NEUROMODULATION MARKET SIZE 17
2.2.1 MARKET SHARE 17
2.2.2 TOP-DOWN APPROACH 17
2.2.3 BOTTOM-UP APPROACH 18
2.2.4 MACRO INDICATOR-BASED APPROACH 19
2.3 ASIA-PACIFIC INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET: MACRO INDICATORS, BY GEOGRAPHY, 2014 ($ BN) 19
2.4 ASSUMPTIONS 20
3 EXECUTIVE SUMMARY 21
4 MARKET OVERVIEW 23
4.1 INTRODUCTION 23
4.2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH THE PARENT MARKET 23
4.3 MARKET DRIVERS AND INHIBITORS 25
5 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY MODALITY 27
5.1 INTRODUCTION 28
5.2 SPINAL CORD STIMULATION 29
5.3 DEEP BRAIN STIMULATION 31
5.4 SACRAL NERVE STIMULATION 33
5.5 VAGUS NERVE STIMULATON 35
5.6 GASTRIC ELECTRICAL STIMULATION (GES) 37
6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY APPLICATION 40
6.1 INTRODUCTION 41
6.1.1 ASIA-PACIFIC SPINAL CORD STIMULATION (SCS) MARKET, BY APPLICATION 41
6.1.2 ASIA-PACIFIC DEEP BRAIN STIMULATION (DBS) MARKET, BY APPLICATION 43
6.1.3 SACRAL NERVE STIMULATION (SNS) MARKET, BY APPLICATION 46
6.1.4 VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION 47
6.1.5 GASTRIC ELECTRICAL STIMULATION (GES) MARKET, BY APPLICATION 49
7 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY GEOGRAPHY 51
7.1 INTRODUCTION 52
7.1.1 JAPAN INTERNAL NEUROSTIMULATION MARKET, BY MODALITY 52
7.1.2 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN JAPAN,
BY APPLICATION 54
7.1.3 DEEP BRAIN STIMULATION (DBS) NEUROSTIMULATION MARKET IN JAPAN,
BY APPLICATION 55
7.1.4 CHINA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY 59
7.1.5 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN CHINA,
BY APPLICATION 60
7.1.6 DEEP BRAIN STIMULATION (SCS) NEUROSTIMULATION MARKET IN CHINA,
BY APPLICATION 61
7.1.7 DEEP BRAIN STIMULATION (SCS) NEUROSTIMULATION MARKET IN CHINA,
BY APPLICATION 62
7.1.8 INDIA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY 65
7.1.9 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN INDIA,
BY APPLICATION 66
7.1.10 DEEP BRAIN STIMULATION (SCS) NEUROSTIMULATION MARKET IN INDIA,
BY APPLICATION 67
7.1.11 REPUBLIC OF KOREA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY 71
7.1.12 DEEP BRAIN STIMULATION (DBS) NEUROSTIMULATION MARKET IN REPUBLIC OF KOREA, BY APPLICATION 73
7.1.13 REST OF ASIA INTERNAL NEUROSTIMULATION MARKET, BY MODALITY 77
7.1.14 SPINAL CORD STIMULATION (SCS) NEUROSTIMULATION MARKET IN REST OF ASIA, BY APPLICATION 78
7.1.15 DEEP BRAIN STIMULATION (DBS) NEUROSTIMULATION MARKET IN REST OF ASIA, BY APPLICATION 79
8 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPETITIVE LANDSCAPE 83
8.1 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: BY COMPANY 83
8.2 NEW PRODUCT LAUNCH 84
9 INTERNAL NEUROSTIMULATION/ NEUROMODULATION MARKET, BY COMPANY 85
(Overview, Financials, Products and Services, Strategy, and Developments)*
9.1 BOSTON SCIENTIFIC CORPORATION (U.S.) 85
9.2 CERBOMED GMBH (GERMANY) 88
9.3 CYBERONICS, INC. (U.S.) 89
9.4 DEPUY SYNTHES COMPANIES (U.S.) 91
9.5 ENTEROMEDICS, INC. (U.S.) 93
9.6 MEDTRONIC, INC. (U.S.) 95
9.7 ST. JUDE MEDICAL (U.S.) 98
9.8 SYNAPSE BIOMEDICAL, INC. (U.S.) 101
9.9 UROPLASTY, INC. (U.S.) 102
*Details on overview, financials, product and services, strategy, and developments might not be captured in case of unlisted company
10 APPENDIX 104
10.1 CUSTOMIZATION OPTIONS 104
10.1.1 PRODUCT ANALYSIS 104
10.1.2 EPIDEMIOLOGY DATA 104
10.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS 104
10.1.4 REGULATORY FRAMEWORK 104
10.2 RELATED REPORTS 105
10.3 INTRODUCING RT: REAL-TIME MARKET INTE

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Biomarker Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Biomarker Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Biomarker Partnering Terms and Agreements 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the biomarker partnering deals ...

Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2016 Competing in the Global Cancer Diagnostics Market

2016 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...


Download Unlimited Documents from Trusted Public Sources

Nursing Home Industry in the UK

  • November 2016
    154 pages
  • Nursing Home  

  • United Kingdom  

View report >

Hospital Industry in the US

  • November 2016
    51 pages
  • Hospital  

  • United States  

View report >

Hospital Statistics in the US

  • November 2016
    70 pages
  • Hospital  

  • United States  

View report >

Hospital Industry

2 months ago

Hospital Industry

2 months ago

Hospital Industry

2 months ago

Hospital Industry

2 months ago

Hospital Industry

2 months ago

Related Market Segments :

Neurological Disorder

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.